Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000231231 | SCV000284078 | pathogenic | Lynch syndrome | 2015-11-27 | criteria provided, single submitter | clinical testing | This sequence change inserts 1 nucleotide in exon 10 of the MLH1 mRNA (c.826dupA), causing a frameshift at codon 276. This creates a premature translational stop signal (p.Ile276Asnfs*31) and is expected to result in an absent or disrupted protein product. Truncating variants in MLH1 are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with Lynch syndrome (PMID: 18809606). For these reasons, this variant has been classified as Pathogenic. |
Invitae | RCV001388953 | SCV001590133 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2015-11-27 | criteria provided, single submitter | clinical testing | Truncating variants in MLH1 are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with Lynch syndrome (PMID: 18809606). For these reasons, this variant has been classified as Pathogenic. This sequence change inserts 1 nucleotide in exon 10 of the MLH1 mRNA (c.826dupA), causing a frameshift at codon 276. This creates a premature translational stop signal (p.Ile276Asnfs*31) and is expected to result in an absent or disrupted protein product. |